UBS Group
EXAR

UBS Group’s Exar Corporation EXAR Stock Holding History

UBS Group’s Portfolio EXAR Stock Details EXAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,995
Closed -$143K – 8361
2017
Q1 		$143K Buy
10,995
+102
+0.9% +$1.09K ﹤0.01% 4861
2016
Q4 		$118K Buy
10,893
+2,019
+23% +$19.6K ﹤0.01% 5182
2016
Q3 		$82K Buy
8,874
+5,146
+138% +$44.9K ﹤0.01% 5125
2016
Q2 		$29K Buy
3,728
+188
+5% +$1.26K ﹤0.01% 5981
2016
Q1 		$20K Sell
3,540
-320
-8% -$1.73K ﹤0.01% 6216
2015
Q4 		$24K Buy
3,860
+599
+18% +$3.67K ﹤0.01% 6579
2015
Q3 		$19K Sell
3,261
-85
-3% -$598 ﹤0.01% 6778
2015
Q2 		$33K Sell
3,346
-1,661
-33% -$17.4K ﹤0.01% 6408
2015
Q1 		$50K Buy
5,007
+2,725
+119% +$27.9K ﹤0.01% 6053
2014
Q4 		$23K Buy
+2,282
New +$21.1K ﹤0.01% 7480

UBS Group's EXAR Position: Q2 2017 in Review

UBS Group sold out of Exar Corporation (EXAR) in Q2 2017, closing a stake of 10,995 shares — an estimated $143K sold.

UBS Group first reported a position in EXAR in Q4 2014 and held it in 10 quarters. The position peaked at $143K in Q1 2017. 0 funds tracked by Wall St. Rank hold EXAR as of Q2 2017.

  • UBS Group reported no remaining Exar Corporation position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 10,995 Exar Corporation shares in Q2 2017, an estimated $143K.
  • UBS Group first reported a position in Exar Corporation in Q4 2014 and held it in 10 quarters.
  • UBS Group's Exar Corporation position peaked at $143K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Exar Corporation as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.